View in EDS HTML Full Text PDF Full Text

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Saved in:
Bibliographic Details
Title: Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
Authors: Jones RL; Royal Marsden Hospital/Institute of Cancer Research, London, UK. robin.jones4@nhs.net., Groisberg R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Blay JY; Centre Léon Bérard, the Comprehensive Cancer Centre, Lyon, France., Colman H; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA., De La Fuente M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Roxburgh P; University of Glasgow, School of Cancer Sciences, Glasgow, UK., Chao MM; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA., Tian H; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA., Duffaud F; CLIP/CEPCM, Aix-Marseille University (AMU), Marseille, France., Bahleda R; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France., Van Tine BA; Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA.
Source: Nature communications [Nat Commun] 2026 Jan 29; Vol. 17 (1). Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41611702
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jones+RL%22">Jones RL</searchLink>; Royal Marsden Hospital/Institute of Cancer Research, London, UK. robin.jones4@nhs.net.<br /><searchLink fieldCode="AU" term="%22Groisberg+R%22">Groisberg R</searchLink>; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Blay+JY%22">Blay JY</searchLink>; Centre Léon Bérard, the Comprehensive Cancer Centre, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Colman+H%22">Colman H</searchLink>; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22De+La+Fuente+M%22">De La Fuente M</searchLink>; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Roxburgh+P%22">Roxburgh P</searchLink>; University of Glasgow, School of Cancer Sciences, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Chao+MM%22">Chao MM</searchLink>; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tian+H%22">Tian H</searchLink>; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Duffaud+F%22">Duffaud F</searchLink>; CLIP/CEPCM, Aix-Marseille University (AMU), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Bahleda+R%22">Bahleda R</searchLink>; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Van+Tine+BA%22">Van Tine BA</searchLink>; Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jan 29; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Jan 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41611702
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-026-68716-6
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jones RL
      – PersonEntity:
          Name:
            NameFull: Groisberg R
      – PersonEntity:
          Name:
            NameFull: Blay JY
      – PersonEntity:
          Name:
            NameFull: Colman H
      – PersonEntity:
          Name:
            NameFull: De La Fuente M
      – PersonEntity:
          Name:
            NameFull: Roxburgh P
      – PersonEntity:
          Name:
            NameFull: Chao MM
      – PersonEntity:
          Name:
            NameFull: Tian H
      – PersonEntity:
          Name:
            NameFull: Duffaud F
      – PersonEntity:
          Name:
            NameFull: Bahleda R
      – PersonEntity:
          Name:
            NameFull: Van Tine BA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 01
              Text: 2026 Jan 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1